Skip to content

Comparative study of sharapunkha siddha tail and povidone iodine ointment in episiotomy wound healing.

Randomised controlled trial of sharpunkha siddha tail with povidone iodine ointment in episiotomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/04/018553
Enrollment
200
Registered
2019-04-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O00-O9A- Pregnancy, childbirth and the puerperium

Interventions

Intervention1: Randomised Controlled trial of Sharapunkha Siddha Tail and Povidone Iodine in episiotomy.: Total 200 patients will be selected by randomization (fishbowl method), they will be alloted t

Sponsors

Shubhangi Anil Kamthe
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: lower socioeconomic class,all types of parity like primi to sixth para

Exclusion criteria

Exclusion criteria: 1.assisted vaginal delivery with episiotomy 2.intra partum complications like convulsion,PPH,MRP,inversion of uterus and third degree perineal tear 3.patient having preexisting or PIH,DM,HTN,TB,thrombocytopenia,severe anaemia,STD and immunocompromised patients

Design outcomes

Primary

MeasureTime frame
To study the efficacy of Sharapunkha Siddha Tail in episiotomy wound.Timepoint: Eight days

Secondary

MeasureTime frame
1.LIterature review of episiotomy will be done 2.drug review,authentication and preparation will be done 3.Patient selection and application will be done 4.effect will be studied 5.Data will be collected 6.Statistical analysis will be done 7.Any adverse effect of Sharapunkha Siddha Tail will be observed.Timepoint: Eight days

Countries

India

Contacts

Public ContactShubhangi Anil Kamthe

Sane Guruji Arogya Kendra

mandaghorpade@yahoo.com9822007570

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026